Introduction
Polymorphisms of gene encoding Angiotensin Converting Enzyme (ACE) and the risk of development of lung cancer have gained special attention in current years (Nacak et al., 2010) . ACE gene located in chromosome 17q23, presents either Insertion (I) or Deletion (D) of 287 base pairs of intron 16 resulting in ID polymorphisms (Li et al., 2014) . ACE is a membrane-bound dipeptidyl carboxypeptidase enzyme of the renin angiotensin system (RAS) (Goto et al., 2005) . It acts as an important regulator of blood pressure and cardiovascular homeostasis by converting angiotensin I into the potent vasoconstrictor angiotensin II and inactivating the known vasodilatorassociations of these studies were inconsistent, plausibly due to inadequate sample size, or varied ethnicity of the study population.
Northeastern parts of India have a very high incidence of cancer of all anatomical sites . Population based cancer registries in India revealed a high incidence of lung cancer in Mizoram, North East India (AAR -28.3 per 100,000 in males and AAR -28.7 per 100,000 in females) (NCRP, 2013) .
Northeastern population especially from Mizoram reveals a unique distribution pattern of ACE genotype (Borah et al., 2011) . Moreover, there is a high consumption of tobacco smoking and chewing and a unique dietary habit among the population of North East India (Chaturvedi et al., 2003; Phukan et al., 2005; Saikia et al., 2014; Phukan et al., 2014) . Considering the extensive role of ACE in the pathogenesis of cancers and a very high incidence of lung cancer in North East, the present study was conducted to explore the association of ACE polymorphisms and its interaction with tobacco smoking and chewing and risk of lung cancer.
The basic design of present study was an age (±5 years), sex and ethnicity matched population based case-control study. The work was carried out by Regional Medical Research Centre (RMRC), Indian Council of Medical Research (ICMR), N.E. Region; India in collaboration with Population based Cancer Registry (PBCR), Imphal, Manipur, India and Civil Hospital, Aizawl, Mizoram, India. The study duration was from June 2009-May 2012. Histopathologically confirmed cases of no evidence of pulmonary inflammation or benign lung tumors and only lung as their primary site of cancer were included in the study. Cases too aged to be interviewed elaborately and who refused to be interviewed were excluded from this study. Cancer free controls with age (±5 years), sex and ethnicity matched were selected from the community population of both the states. In order to reduce potential bias in our study, none of the controls had consanguinity with the cases or had any non-communicable diseases. Information of sociodemographic characteristics, smoking and chewing of tobacco were recorded in a structured predesigned questionnaire. All subjects were provided written informed consent for participation in the study which was designed under a protocol approved by institutional ethical committee of Regional Medical Research Centre, Northeast region (Indian Council of Medical Research). Of 155 lung cancer cases collected, 4 cases were excluded because they had a missing histology and blood sample. Hence, a total of 151 lung cancer cases and 151 controls matched for (±5 years), sex and ethnicity were enrolled in the study.
DNA extraction and genotyping of ACE gene polymorphisms
Four ml. of blood was collected from all the subjects in EDTA vials. DNA was isolated by using standard phenol chloroform method and stored at -80ºC until further analysis (Sambrook and Russel, 2001) . ACE gene ID polymorphisms was determined by polymerase chain reaction (PCR) using the following oligonucleotide primers: 5'-GCC CTG CAG GTG TCT GCA GCA TGT-3' (forward) and 5'-GGA TGG CTC TCC CCG CCT TCT CTC-3' (reverse) to amplify D and I alleles (Borah et al., 2012) , of 319 and 597 bp products. PCR amplification used 25.0 μl reaction volumes and consisted of 10 pmol of each primer (Sigma), 10mM Tris-HCL, pH 9.0 (Roche), 10mM dNTPs, 1U of Taq. DNA polymerase (Roche) and 50-100 ng of genomic DNA. Amplification cycle was carried on Gene Amp PCR System 9700: Version 3.08 thermal cycler (Applied Biosystems, USA) following standard protocol. Amplified PCR products were run on 2% agarose gel electrophoresis with ethidium bromide and were visualized in a gel documentation system (Cell Biosciences). Insertion (I) or Deletion (D) of 287 bp Alu repeat in intron 16 resulting in one of the three genotypes viz. insertion homozygous (II), deletion homozygous (DD) or insertion-deletion (ID) heterozygous and was detected. Thus, each DNA sample revealed one of the three possible patterns after electrophoresis: a 597 bp band (II genotype), a 319 bp band (DD genotype) or both 597 bp and 319 bp bands (ID genotype) ( Figure 1 ). Samples with DD genotype were again processed to a second PCR amplification with insertion-specific primer (5` TTT GAG ACG GAG TCT CGC TC 3`) to evade DD mistyping (Shanmugam et al., 1993) .
Statistical analysis
Differences in the consumption of dietary habits, distribution of sociodemographic characteristics and genotype frequencies between cases and controls were evaluated using the Chi Square ( DOI:http://dx.doi.org/10.7314/APJCP.2014.15.24.10691 ACE Gene Interaction with Smoking and Chewing for Lung Cancer in North-East India. deriving the odds ratio (OR) and its corresponding 95% confidence interval (95%CI) using multivariable conditional logistic regression after adjusting with potential confounders. For all tests a two sided p≤0.05 was considered statistically significant. All statistical analysis were done using SPSS version 17.0.
Results
The 
Discussion
Present study revealed significant association of ACE II genotype with lung cancer. The pathophysiological basis for association of ACE gene polymorphisms and risk of lung cancer may be related to its activity on BK. BK moderate mitogenic activity (Drube and Liebmann, 2000; Kramarenko et al., 2012) . Such activities may be implicated in development of lung cancer. ACE inactivates BK (Kuoppala et al., 2000) and may reduce carcinogenic potential of this neuropeptide. Such inactivation may be genetically dependent because half of the interindividual difference in ACE levels may be explained by its polymorphisms (Gard, 2010) with highest concentration in DD genotype and lowest in II genotype. Subjects with II genotype with low concentration of ACE level have the less capacity to inactivate BK and therefore mitogenic potential of BK in these subjects may be enhanced. Frequency of the variant II genotype was significantly higher in the lung cancer patients than in control subjects (40.4 vs 29.1%; p=0.037). This may result from decreased inactivation of BK and thereby might increase mitogenic effects of BK in lung cancer. Another reason could be that inflammation induced by BK might be involved in the development of lung carcinogenesis.
For studying the role of gene-environment interaction that might modify susceptibility of lung cancers, potential interactions of ACE genotype with known risk factors were analysed. When analysed for ACE interaction with tobacco smoking and chewing for lung cancer, significantly enhanced risk was observed for ACE II genotype with both smoking and chewing. Thus, our results may indicate a tissue and carcinogen-specific modulation of cancer risk by ACE gene polymorphisms and is contrary to the classical roles assumed for the genetic variants of the genes. However, mechanistic explanation for association of variants with lung cancer might not be so clear and straight forward, genetic characterizations as linkage disequilibrium of the variants with certain functional polymorphisms could exist (Chung et al., 2013) . Perhaps, investigating the mutational status of tumour and its correlations could possibly provide a better understanding. Observations for association of ACE gene polymorphisms with any types of cancer were reported to be inconsistent in different ethnic and geographical regions. Study conducted by Cheon et al. (2000) found no significant difference between ACE ID polymorphisms and risk of lung cancer. However, contrary to this study, Pavlic et al. (2012) observed significant association for ACE DD Genotype for lung cancer. As for other cancers, including those of oral, breast, prostate and endometrium, associations with the ACE ID polymorphisms have been examined (Freitas-Silva et al., 2004; Yigit et al., 2007; Vairaktaris et al., 2007; Correa et al., 2009 ). Correa et al. (2009) reported that ACE ID might be more protective against breast cancer than DD and II, while Koh et al. (2003) have shown that I allele reduced the risk in Chinese and Haiman et al. (2003) have discovered that II had a marginally significant risk in African-Americans. The ACE DD posed a significantly higher risk genotype for prostate cancer (Yigit et al., 2007) , whereas for oral cancer, I allele was significantly higher risk allele (Vairaktaris et al., 2007) . In endometrial cancer, I allele carriers were at significantly higher risk among normotensive women aged 63 years or younger (Freitas-Silva et al., 2004) .
Current study has several strengths and findings. It is a population based case control study and was carried out in a high risk area of lung cancer from Northeast India. Present study showed independent association of ACE polymorphisms with lung cancer. This information is new in the context that data related to ACE gene polymorphisms and the risk of lung cancer is not available for the South Asian population. Therefore, a comprehensive study may bring us with some interesting findings. Our study warrants need of understanding association of ACE polymorphisms with BK. The main limitation of our study is the lack of information of plasma ACE concentration of the study subjects in respect to ACE genotype.
Previous studies (Keavney et al., 1998; Chung et al., 2013) on segregation-linkage analysis suggested the existence of a functional mutation located within or close to the ACE locus, which might be in almost complete linkage disequilibrium with the ACE ID polymorphisms and accounts for half the variance of plasma concentration of ACE. Therefore, evaluation of both these markers at a time may not be required.
The present study indicates significant association of ACE II genotype with lung cancer in a high risk northeastern population. Our findings suggest role of ethnicity on ACE polymorphisms for lung cancer risk. Results of our study also indicate significant interaction of tobacco smoking and chewing with ACE II genotype. However, validation of results will require replication in a larger sample size. Taking into account other confounders such as dietary habits and environmental factors can give a more conclusive perspective.
